Ruxolitinib is a cornerstone of management for some subsets of myeloproliferative neoplasms (MPNs); however. a considerable number of patients respond suboptimally. Here. we evaluated the efficacy of micheliolide (MCL). https://fitnessgravesyardes.shop/product-category/right-rear-endcap/